Alpha-adrenergic stimulation of adult rat ventricular cardiocytes with phenylephrine significantly increased NCX mRNA (2.5-fold) and protein levels (1.8-fold).
Does alpha-adrenergic stimulation up-regulate NCX expression in adult rat ventricular cardiocytes?
Alpha-adrenergic stimulation up-regulates the expression of the sarcolemmal Na+/Ca2+-exchanger in adult rat ventricular cardiocytes, suggesting a mechanism for altered Ca2+ homeostasis in cardiac hypertrophy.
Estimación del efecto: 2.5-fold increase in mRNA, 1.8-fold increase in protein
OBJECTIVE: The cardiac sarcolemmal Na+/Ca(2+)-exchanger (NCX) plays an important role in the maintenance of the myocardial Ca2+ homeostasis which is altered in cardiac hypertrophy and failure. The aim of the present study was to investigate whether alpha-adrenergic stimulation known to induce cardiac hypertrophy might be involved in the regulation of the sarcolemmal NCX. METHODS: Adult rat ventricular cardiocytes (ARC) were isolated from male Sprague-Dawley rats. Phenylephrine, an alpha-adrenergic agonist, was used as hypertrophic agent. NCX expression was measured by competitive RT-PCR and Western blot analysis. RESULTS: alpha-Adrenergic stimulation of ARC with 10 microM phenylephrine for 24 h resulted in a significant increase of the NCX mRNA (2.5-fold) and the NCX protein level (1.8-fold). The changes on the expression level were blocked by the alpha 1-adrenoceptor antagonist prazosin. CONCLUSIONS: The data demonstrate that the NCX expression level is up-regulated by the activation of the alpha-adrenergic signal transduction pathway. The increased NCX mRNA level induced by alpha-adrenergic stimulation appeared to be translated into increased NCX protein level.
Hans Reinecke (Sat,) conducted a other in Cardiac hypertrophy model. Phenylephrine vs. Control was evaluated on NCX mRNA and protein level expression (2.5-fold increase in mRNA, 1.8-fold increase in protein). Alpha-adrenergic stimulation of adult rat ventricular cardiocytes with phenylephrine significantly increased NCX mRNA (2.5-fold) and protein levels (1.8-fold).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: